The expression of uPAR in the kidney and the concentrations of suPAR in the blood are consistently elevated in patients with kidney diseases, especially with focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy6–8. This evidence concerns the gene PLAUR and focal segmental glomerulosclerosis.